Huntsman Cancer Institute (HCI) at the University of Utah today announced the appointment of Cornelia Ulrich, PhD, MS, as director of its National Cancer Institute-Designated Comprehensive Cancer Center. She will oversee HCI’s academic consortium of nearly 200 cancer research teams. Ulrich will lead efforts to advance HCI’s research in laboratory, clinical and population science, with the goal of improving cancer prevention and treatment. – Huntsman Cancer Institute (HCI) at the University of Utah today announced the appointment of Cornelia Ulrich, PhD, MS, as director of its National Cancer Institute-Designated Comprehensive Cancer Center. She will oversee HCI’s academic consortium of nearly 200 cancer research teams. Ulrich will lead efforts to advance HCI’s research in laboratory, clinical and population science, with the goal of improving cancer prevention and treatment. ... Read MoreSelect...
Huntsman Cancer Institute (HCI) physician-scientist Ahmad Halwani, MD, has been selected by the National Cancer Institute (NCI) to receive a Cancer Clinical Investigator Team Leadership Award. This award recognizes physician-scientists for their contributions to clinical cancer research. It also provides financial support for ongoing research and leadership development to enable recipients to further advance their clinical research careers.... Read MoreSelect...
Huntsman Cancer Institute Partners with Nation’s Top Cancer Centers to Endorse Goal of Eliminating HPV Related Cancers in the United States
Nearly 80 million Americans — one out of every four people — are infected with human papillomavirus (HPV). And of those millions, more than 31,000 will be diagnosed with an HPV-related cancer this year. Despite those staggering figures and the availability of a vaccine to prevent the infections that cause these cancers, HPV vaccination remains low in the United States. ... Read MoreSelect...
Scientists at University of Utah Health are using animals' unique traits to pinpoint regions of the human genome that might affect health. The results of this project are available in the March 6 issue of the journal Cell Reports.... Read MoreHuman Genetics
Scientists have had limited success at identifying specific inherited genes associated with prostate cancer. Researchers studied prostate cancer patients with multiple cancer diagnoses, many who would not be recommended for genetic tests following current guidelines, to identify genetic mutations that may influence cancer risk. ... Read MoreHuman Genetics
Patients undergoing chemotherapy often experience difficult but treatable symptoms – including fatigue, pain, and nausea - in between healthcare appointments. But because providers are often not aware of them, some patients undergo unnecessary suffering. A new study by investigators at Huntsman Cancer Institute and the College of Nursing at the University of Utah shows that relief could be just a phone call away.... Read MoreSelect...,Oncological Sciences
Precision medicine promises health care tailored to every individual, a mission that opens exciting possibilities and poses unique challenges. How do we control cost, equalize access to care, and speed the journey to success? On Dec 1 and 2, 2016, scientists, doctors, lawyers, and ethicists from across the country met to discuss these topics, and more.... Read MoreSelect...,Oncological Sciences,Internal Medicine,Human Genetics,Pediatrics
Huntsman Cancer Institute One of the Top in the Nation; University of Utah Hospital Best in Utah, according to latest U.S. News & World Report Rankings
U.S. News & World Report has released its 2016-2017 Best Hospital Rankings and named University of Utah’s Huntsman Cancer Institute (HCI) one of the top 50 cancer hospitals in the country. ... Read MoreHuman Genetics
Despite studies that claim people with cancer are less likely to develop Alzheimer’s disease--raising the possibility that what triggers cancer also prevents the neurodegenerative disorder--a new investigation finds a more somber explanation. Many cancer patients don’t live long enough to get Alzheimer’s. The research, led by investigators at Huntsman Cancer Institute at the University of Utah, was published in The Journals of Gerontology: Series B.... Read MoreFamily and Preventive Medicine
Cancer usually begins in one location and then spreads, but in 3-5% of cancer patients, the tissue where a cancer began is unknown. In these individuals a cancer diagnosis is made because it has metastasized to other sites. Patients with these so-called “cancers of unknown primary,” or CUP, have a very poor prognosis, with a median survival of three months. A new study in the Journal of the American Medical Association (JAMA) Oncology finds that family members of CUP patients are at higher risk of developing CUP themselves, as well as cancers of the lung, pancreas, colon, and some cancers of the blood.... Read MoreSelect...
A study led by the Huntsman Cancer Institute at the University of Utah could explain why elephants rarely get cancer. Published in the Journal of the American Medical Association (JAMA), the results show that elephants have extra modified copies of a gene encoding a well known cancer inhibitor, p53. The elephants may also have a more robust mechanism for killing damaged cells that are at risk for becoming cancerous. The findings suggest extra p53 could explain elephants’ enhanced cancer resistance and lead to new strategies for treating cancer in people. Pediatric oncologist Joshua Schiffman, who led the study, describes the research and what it could mean for treating cancer in people.... Read MoreOncological Sciences
Researchers have found that multiple myeloma patients with a genetic variation in the gene FOPNL die on average 1-3 years sooner than patients without it. The finding was identified with a genetic mapping technique, genome wide association studies (GWAS), and verified in patient populations from North America and Europe. Published in Nature Communications, this was the first study to survey the entire human genome for genetic variation influencing survival, and is a first step toward applying precision medicine to multiple myeloma.... Read MoreBiomedical Informatics,Internal Medicine
Mario R. Capecchi, PhD, will be honored for his tremendous scientific contributions, which have had a profound impact on the understanding of cancer, including his groundbreaking work in the development of gene targeting technology, with the 12th annual American Association for Cancer Research (AACR) Award for Lifetime Achievement in Cancer Research at the AACR Annual Meeting 2015, to be held in Philadelphia, April 18-22. ... Read MoreHuman Genetics
Martin McMahon, Ph.D., joins Huntsman Cancer Institute (HCI) at the University of Utah in August as Professor in the Department of Dermatology and HCI Senior Director of Pre-Clinical Translation. ... Read MoreDermatology,Oncological Sciences
A discovery by researchers at Huntsman Cancer Institute shows that looking at whether a man’s uncles and great-grandparents, among other second- and third-degree relatives, had prostate cancer could be as important as looking at whether his father had prostate cancer. A more complete family history would give physicians a new tool to decide whether or not a PSA test was appropriate.... Read MoreInternal Medicine